This chapter describes the potential relationship of COVID-19 vaccines and thrombosis with thrombocytopenia syndrome (TTS), immune thrombocytopenic purpura (ITP), and capillary leak syndrome (CLS) ...
An expert discusses treatment strategies for immune thrombocytopenic purpura (ITP), emphasizing individualized decisions based on platelet count, bleeding symptoms, and comorbidities, with options ...
The New England Journal of Medicine: Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura
An expert discusses the clinical presentation and diagnosis of immune thrombocytopenic purpura (ITP), emphasizing that isolated thrombocytopenia with mucosal bleeding and petechiae is highly ...
Thrombotic thrombocytopenic purpura (TTP) and immune thrombocytopenia (ITP) are both blood disorders that affect blood clotting. TTP is more serious than ITP. The term “thrombocytopenia” refers to low ...
Researchers from the Second Affiliated Hospital of Nanjing Medical University, et al. have published a case report entitled "Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with ...
ascopubs.org: Outcomes of rituximab as treatment for immune thrombocytopenic purpura in patients who have failed steroids or IVIG: A retrospective study in a community practice.
Outcomes of rituximab as treatment for immune thrombocytopenic purpura in patients who have failed steroids or IVIG: A retrospective study in a community practice.
EurekAlert!: Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac
The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP).
Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac
MSN: Examining two cases of immune thrombotic thrombocytopenic purpura associated with COVID-19 vaccine CoronaVac
Examining two cases of immune thrombotic thrombocytopenic purpura associated with COVID-19 vaccine CoronaVac